METABASIS THERAPEUTICS
Metabasis is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs by applying its proprietary technologies, scientific expertise and unique capabilities for targeting the liver and liver pathways. The Company has established a broad pipeline of product candidates and advanced research programs targeting large markets with significant unmet needs. Metabasis' product pipeline represents candidates indicated for the treatment of metabolic diseases s... uch as hyperlipidemia and diabetes, among others. Additionally, our pipeline includes drug candidates for the treatment of liver diseases such as hepatitis and primary liver cancer which the company plans to license to companies focused on these areas. All of our product candidates were developed internally using proprietary technologies including our NuMimetic and HepDirect technologies.
METABASIS THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
1997-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.mbasis.com
Total Employee:
1+
Status:
Closed
Contact:
(858) 587-2770
Technology used in webpage:
Domain Not Resolving
Current Advisors List
Stock Details
More informations about "Metabasis Therapeutics"
Introduction to mBASIS | Midas Docs
Midas Basis Trading Token (mBASIS) is a permissionless yield-bearing token tracking a delta-neutral basis trading strategy. Basis Trading in Crypto Markets: Basis trading is a common, …See details»
mBASIS | Midas Docs
?Introduction to mBTC. ⚙️How mBTC Works. Issuance & Redemption. Yield Distribution. Fees. ?⚖️Bankruptcy Remoteness. Resources. ⛓️Smart Contracts Addresses. ?Audits.See details»
Midas is thrilled to announce the launch of mBASIS, a …
Jun 20, 2024 · Midas’s mBASIS gives token-holders exposure to an institutional-grade basis trading strategy. This strategy takes advantage of profitable crypto-basis positions during bull …See details»
Internet Native Investing | Midas
Assets safeguarded in a bankruptcy-remote structure. Independent and transparent performance reporting. Regulatory compliant and authorized for retail distribution under European securities …See details»
Midas launches new yield-bearing token mBASIS to …
Jun 20, 2024 · Midas, a tokenization platform backed by Coinbase Ventures and others, has launched a new yield-bearing token called mBASIS. mBASIS is a dollar-denominated ERC-20 …See details»
RWA Issuer Midas Expands Tokenized Products to Retail …
Oct 8, 2024 · Midas launched its own version with mBASIS earlier this year, and has over $4 million of assets under management.See details»
Midas: Internet Native Investing.
When Fabrice and I founded Midas, our mission was simple: to make investing and saving as open and accessible as the internet. The transparency and openness of public blockchain …See details»
Independent Reporting | Midas Docs
To ensure you have full visibility into your investment, Midas provides comprehensive data reporting for mBASIS through the following measures: Independent Fund Administrator: The …See details»
Midas Launches mBASIS: A Tokenized Basis Trading …
Jun 20, 2024 · Unlike Ethena’s product, mBASIS is managed by a leading, licensed asset manager who operates under fiduciary duty, ensuring that the investment process aligns with …See details»
Understanding Key Terms | Midas Docs
Oct 8, 2024 · mBasis employs a variety of derivatives to execute its basis trading strategy effectively. Understanding the following key terms is essential for grasping the intricacies of …See details»
Internet Native Investing | Midas
Institutional-grade assets built for the open web.See details»
In an EU first, tokenization firm Midas opens mTBILL and …
Oct 8, 2024 · Midas’ onchain mTBILL and mBASIS tokens will be the first such real-world asset trading vehicles available to non-accredited investors. The tokenization firm received …See details»
Metabasis Therapeutics, Inc. Initiates A Phase 1 Clinical
Oct 30, 2006 · Metabasis Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs to address some of the world’s …See details»
MBASIS to CAD: Midas Basis Trading Token Price in …
Nov 18, 2024 · The conversion rate of Midas Basis Trading Token (MBASIS) to CAD is CA$1.46 for every 1 MBASIS. This means you can exchange 5 MBASIS for CA$7.28 or CA$50.00 for …See details»
Midas Basis Trading Token MBASIS Price, Live Charts, …
Oct 30, 2024 · Midas Basis Trading Token is on the rise this week. The current price is $1.01 per MBASIS with a 24-hour trading volume of $0.00. The new price represents a new all time high …See details»
Midas Basis Trading Token MBASIS Price, Live Charts, …
Get the latest price, news, live charts, and market trends about Midas Basis Trading Token. The current price of Midas Basis Trading Token in Canada is CA$NaN per (MBASIS / CAD)See details»
Investment Strategy | Midas Docs
Understanding mBASIS Investment Strategy. The mBASIS product tracks a basis trading strategy to generate yield by capitalizing on the funding rate of perpetual futures contracts and the …See details»
Risks | Midas Docs
Investing in mBASIS involves certain risks, and it’s important for investors to fully understand these before engaging. While Midas employs robust risk management strategies, the following …See details»
代币化平台Midas推出mBASIS与Ethena竞争 - BlockBeats
BlockBeats 消息，6 月 21 日，据 TheBlock 报道，由 Coinbase Ventures 等支持的代币化平台 Midas 宣布推出名为 mBASIS 的 ERC-20 代币，以美元计价，旨在通过 delta 中性基差交易策 …See details»